Refine
Year of publication
Language
- English (164)
Has Fulltext
- yes (164)
Is part of the Bibliography
- no (164)
Keywords
- SARS-CoV-2 (5)
- COVID19-NMR (4)
- Solution NMR spectroscopy (4)
- copyright (4)
- journals (4)
- paywalls (4)
- 5′-UTR (3)
- Diffraction (3)
- Elastic scattering (3)
- LibGen (3)
- Sci-Hub (3)
- data-science (3)
- literature (3)
- piracy (3)
- publishing (3)
- Collectivity (2)
- Correlation (2)
- Polarization (2)
- RHIC (2)
- Shear viscosity (2)
- open-access (2)
- 5'-UTR (1)
- 5_SL4 (1)
- ABC transporters (1)
- ATPases (1)
- Absenteeism (1)
- B-slope (1)
- Cancer (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Canopy height model (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Covid19-nmr (1)
- Critical point (1)
- Data sharing (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Elliptic flow (1)
- Entomology (1)
- Feature article (1)
- Flow (1)
- Forward physics (1)
- Genomic instability (1)
- Groomed jet radius (1)
- Hadron-Hadron scattering (experiments) (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Heavy-ion collisions (1)
- Higher moments (1)
- Interference fragmentation function (1)
- J/ψ suppression (1)
- Jet substructure (1)
- Kidney neoplasm (1)
- Minimally invasive surgical procedures (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- NMR spectroscopy (1)
- Nephrectomy (1)
- Nonflow (1)
- Opioids (1)
- Phylogenomics (1)
- Population genetics (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Quarkonium (1)
- RNA (1)
- RNA genome (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- STAR (1)
- SoftDrop (1)
- Spin alignment (1)
- Splitting function (1)
- Thermal model (1)
- Transversity (1)
- UAV (1)
- X-ray crystallography (1)
- aging (1)
- alleles (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- cirrhosis (1)
- clinically important restrictions and symptoms (1)
- copy number polymorphism (1)
- cryo-EM (1)
- drone (1)
- fine spatial resolution remote sensing (1)
- fragment screening (1)
- genes (1)
- genes for longevity (1)
- genetics (1)
- genome (1)
- genotype (1)
- genotype determination (1)
- global change (1)
- habitat destruction (1)
- health-related quality of life (1)
- land use (1)
- libgen (1)
- membrane proteins (1)
- molecular machines (1)
- observational study (1)
- open access (1)
- open-data (1)
- p+p collisions (1)
- phenotype (1)
- phylogeny (1)
- plant height (1)
- portal hypertension (1)
- primary active transporters (1)
- rare disease (1)
- renin-angiotensin system (1)
- sarcoma (1)
- sci-hub (1)
- senescence (1)
- sequence alignment (1)
- signal transduction (1)
- single nucleotide polymorphism (1)
- structural biology (1)
- structure-from-motion photogrammetry (1)
Institute
- Physik (93)
- Frankfurt Institute for Advanced Studies (FIAS) (37)
- Medizin (14)
- Biowissenschaften (10)
- Biochemie, Chemie und Pharmazie (6)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Biochemie und Chemie (1)
- Exzellenzcluster Makromolekulare Komplexe (1)
- Geographie (1)
Monte Carlo (MC) simulations are an essential tool to determine fundamental features of a neutron beam, such as the neutron flux or the γ-ray background, that sometimes can not be measured or at least not in every position or energy range. Until recently, the most widely used MC codes in this field had been MCNPX and FLUKA. However, the Geant4 toolkit has also become a competitive code for the transport of neutrons after the development of the native Geant4 format for neutron data libraries, G4NDL. In this context, we present the Geant4 simulations of the neutron spallation target of the n_TOF facility at CERN, done with version 10.1.1 of the toolkit. The first goal was the validation of the intra-nuclear cascade models implemented in the code using, as benchmark, the characteristics of the neutron beam measured at the first experimental area (EAR1), especially the neutron flux and energy distribution, and the time distribution of neutrons of equal kinetic energy, the so-called Resolution Function. The second goal was the development of a Monte Carlo tool aimed to provide useful calculations for both the analysis and planning of the upcoming measurements at the new experimental area (EAR2) of the facility.
Sarcomas are rare cancers with high heterogeneity in terms of type, location, and treatment. The health-related quality of life (HRQoL) of sarcoma patients has rarely been investigated and is the subject of this analysis. Adult sarcoma patients and survivors were assessed between September 2017 and February 2019 in 39 study centers in Germany using standardized, validated questionnaires (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)). Associated factors were analyzed exploratively using multivariable linear regressions. Among 1113 patients, clinically important limitations and symptoms were most pronounced in emotional (63%, 95% CI 60–66%), physical (60%, 95% CI 57–62%), role functioning (51%, 95% CI 48–54%), and pain (56%, 95% CI 53–59%) and fatigue (51%, 95% CI 48–54%). HRQoL differed between tumor locations with lower extremities performing the worst and sarcoma types with bone sarcoma types being most affected. Additionally, female gender, higher age, lower socioeconomic status, recurrent disease, not being in retirement, comorbidities, and being in treatment were associated with lower HRQoL. Sarcoma patients are severely restricted in their HRQoL, especially in functioning scales. The heterogeneity of sarcomas with regard to type and location is reflected in HRQoL outcomes. During treatment and follow-up, close attention has to be paid to the reintegration of the patients into daily life as well as to their physical abilities and emotional distress.
Men and women differ substantially regarding height, weight, and body fat. Interestingly, previous work detecting genetic effects for waist-to-hip ratio, to assess body fat distribution, has found that many of these showed sex-differences. However, systematic searches for sex-differences in genetic effects have not yet been conducted. Therefore, we undertook a genome-wide search for sexually dimorphic genetic effects for anthropometric traits including 133,723 individuals in a large meta-analysis and followed promising variants in further 137,052 individuals, including a total of 94 studies. We identified seven loci with significant sex-difference including four previously established (near GRB14/COBLL1, LYPLAL1/SLC30A10, VEGFA, ADAMTS9) and three novel anthropometric trait loci (near MAP3K1, HSD17B4, PPARG), all of which were significant in women, but not in men. Of interest is that sex-difference was only observed for waist phenotypes, but not for height or body-mass-index. We found no evidence for sex-differences with opposite effect direction for men and women. The PPARG locus is of specific interest due to its link to diabetes genetics and therapy. Our findings demonstrate the importance of investigating sex differences, which may lead to a better understanding of disease mechanisms with a potential relevance to treatment options.
Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
(2017)
Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.
Chordomas are rare bone tumors with few therapeutic options. Here we show, using whole-exome and genome sequencing within a precision oncology program, that advanced chordomas (n = 11) may be characterized by genomic patterns indicative of defective homologous recombination (HR) DNA repair and alterations affecting HR-related genes, including, for example, deletions and pathogenic germline variants of BRCA2, NBN, and CHEK2. A mutational signature associated with HR deficiency was significantly enriched in 72.7% of samples and co-occurred with genomic instability. The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib, which is preferentially toxic to HR-incompetent cells, led to prolonged clinical benefit in a patient with refractory chordoma, and whole-genome analysis at progression revealed a PARP1 p.T910A mutation predicted to disrupt the autoinhibitory PARP1 helical domain. These findings uncover a therapeutic opportunity in chordoma that warrants further exploration, and provide insight into the mechanisms underlying PARP inhibitor resistance.
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.